Literature DB >> 17689286

Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.

Karien I E M Wijffels1, Henri A M Marres, Johannes P W Peters, Paulus F J W Rijken, Albert J van der Kogel, Johannes H A M Kaanders.   

Abstract

Two mechanisms of radiotherapy resistance of major importance in head and neck cancer are tumour cell repopulation and hypoxia. Hypoxic tumour cells that retain their clonogenic potential can survive radiation treatment and lead to local recurrences. The aim of this study was to quantify this cellular population in a cohort of human head and neck carcinomas and to investigate the prognostic significance. The proliferation marker iododeoxyuridine (IdUrd) and the hypoxia marker pimonidazole were administered intravenously prior to biopsy taking in patients with stage II-IV squamous cell carcinoma of the head and neck. Triple immunohistochemical staining of blood vessels, IdUrd and pimonidazole was performed and co-localization of IdUrd and pimonidazole was quantitatively assessed by computerized image analysis. The results were related with treatment outcome. Thirty-nine biopsies were analyzed. Tumours exhibited different patterns of proliferation and hypoxia but generally the IdUrd signal was found in proximity to blood vessels whereas pimonidazole binding was predominantly at a distance from vessels. Overall, no correlations were found between proliferative activity and oxygenation status. The fraction of IdUrd-labelled cells positive for pimonidazole ranged from 0% to 16.7% with a mean of 2.4% indicating that proliferative activity was low in hypoxic areas and occurring mainly in the well-oxygenated tumour compartments. IdUrd positive cells in hypoxic areas made up only 0.09% of the total viable tumour cell mass. There were no associations between the magnitude of this cell population and local tumour control or survival. Co-localization between proliferating cells and hypoxia in head and neck carcinomas was quantified using an immunohistochemical triple staining technique combined with a computerized simultaneous analysis of multiple parameters. The proportion of cells proliferating under hypoxic conditions was small and no correlation with treatment outcome could be found.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17689286     DOI: 10.1016/j.oraloncology.2007.04.004

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  12 in total

1.  Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC).

Authors:  Nadarajah Vigneswaran; Jean Wu; Anren Song; Ananth Annapragada; Wolfgang Zacharias
Journal:  Exp Mol Pathol       Date:  2011-01-12       Impact factor: 3.362

2.  The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study.

Authors:  Sydney M Evans; Kevin W Jenkins; H Isaac Chen; W Timothy Jenkins; Kevin D Judy; Wei-Ting Hwang; Robert A Lustig; Alexander R Judkins; M Sean Grady; Stephen M Hahn; Cameron J Koch
Journal:  Transl Oncol       Date:  2010-06-01       Impact factor: 4.243

3.  Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response.

Authors:  J Jeong; K I Shoghi; J O Deasy
Journal:  Phys Med Biol       Date:  2013-06-21       Impact factor: 3.609

4.  Modeling the relationship between fluorodeoxyglucose uptake and tumor radioresistance as a function of the tumor microenvironment.

Authors:  Jeho Jeong; Joseph O Deasy
Journal:  Comput Math Methods Med       Date:  2014-09-08       Impact factor: 2.238

5.  The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer.

Authors:  H B Ragnum; L Vlatkovic; A K Lie; K Axcrona; C H Julin; K M Frikstad; K H Hole; T Seierstad; H Lyng
Journal:  Br J Cancer       Date:  2014-12-02       Impact factor: 7.640

6.  Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.

Authors:  Mingyang Ma; Shuyao Hua; Gang Li; Sumei Wang; Xue Cheng; Songqing He; Ping Wu; Xiaoping Chen
Journal:  Oncotarget       Date:  2017-02-21

7.  Arterial Spin Labeling and Dynamic Susceptibility Contrast-enhanced MR Imaging for evaluation of arteriovenous shunting and tumor hypoxia in glioblastoma.

Authors:  S Ali Nabavizadeh; Hamed Akbari; Jeffrey B Ware; MacLean Nasrallah; Samantha Guiry; Stephen J Bagley; Arati Desai; Scott Levy; Whitney Sarchiapone; Timothy Prior; John Detre; Ronald L Wolf; Donald M O'Rourke; Steven Brem; Christos Davatzikos
Journal:  Sci Rep       Date:  2019-06-19       Impact factor: 4.379

8.  Biological characteristics of intratumoral [F-18]‑fluoromisonidazole distribution in a rodent model of glioma.

Authors:  Toshiyuki Hatano; Songji Zhao; Yan Zhao; Ken-Ichi Nishijima; Norihito Kuno; Hiroko Hanzawa; Takeshi Sakamoto; Nagara Tamaki; Yuji Kuge
Journal:  Int J Oncol       Date:  2013-01-18       Impact factor: 5.650

9.  Evaluation of the Combined Effect of 2ME2 and (60)Co on the Inducement of DNA Damage by IUdR in a Spheroid Model of the U87MG Glioblastoma Cancer Cell Line Using Alkaline Comet Assay.

Authors:  Samideh Khoei; Sara Delfan; Ali Neshasteh-Riz; Seyed Rabi Mahdavi
Journal:  Cell J       Date:  2011-08-24       Impact factor: 2.479

10.  Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors.

Authors:  Bianca A W Hoeben; Maud H W Starmans; Ralph T H Leijenaar; Ludwig J Dubois; Albert J van der Kogel; Johannes H A M Kaanders; Paul C Boutros; Philippe Lambin; Johan Bussink
Journal:  BMC Cancer       Date:  2014-02-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.